Home

Athyrium Opportunities III Acquisition LP

CIK 1835266 · last filed 2021-06-14

Athyrium Opportunities III Acquisition LP is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider bought $180.0M of PROG on Jun 14, 2021. Across all open-market trades the lifetime net is +$180.0M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 11 SEC filings were submitted jointly with Athyrium Funds GP Holdings LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$180.00M

Filer Profile

Reported Address
505 FIFTH AVENUE, 18TH FLOOR
NEW YORK, NY 10017
Phone
(646) 434-1636
State of Incorporation
DE
Related Filers
Athyrium Funds GP Holdings LLC — 11 joint filings, latest 2024-12-16
Jeffrey Ferrell — 11 joint filings, latest 2024-12-16
Athyrium Opportunities 2020 LP — 8 joint filings, latest 2024-12-16
Athyrium Opportunities Associates III GP LLC — 8 joint filings, latest 2024-12-16
Athyrium Opportunities III Acquisition 2 LP — 8 joint filings, latest 2024-12-16
Athyrium Capital Holdings, LLC — 3 joint filings, latest 2021-06-14
Athyrium Capital Management, LP — 3 joint filings, latest 2021-06-14
NB Alternatives Advisers LLC — 3 joint filings, latest 2021-06-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIORA THERAPEUTICS, INC. (PROG) Delisted 10%+ Owner 36,396,907 $0.88 $32.19M $180.00M 1 2021-06-14

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-06-14 BIORA THERAPEUTICS, INC. (PROG) Delisted Buy (P) +72,874,494 $180.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.